1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Corrigendum to 'Acute cognitive effects of high doses of dextromethorphan relative to triazolam in h

Corrigendum to 'Acute cognitive effects of high doses of dextromethorphan relative to triazolam in h

  1. Behrang
    Drug and Alcohol Dependence 133 (2013) 294

    Lawrence P. Carter, Chad J. Reissig, Matthew W. Johnson, Margaret A. Klinedinst,
    Roland R. Griffiths, Miriam Z. Mintzerd

    The authors regret that in this paper it was incorrectly reported that the study drug dextromethorphan (DXM) was administered as the hydrobromide salt. In fact, the base form of the drug was administered. Although this is a relatively minor oversight, following correction is submitted for scientific accuracy.
    Under section “2.3 Drugs” of the materials and methods (page 2 of the manuscript). The last three sentences should be corrected as follows:
    “...powdered dextromethorphan (Spectrum Chemical, Gardena CA, USA) and lactose; or commercially available crushed triazolam tablets (Halcion; The Upjohn Company, Kalamazoo, MI, USA) and lactose. All doses were adjusted for participant body weight. Doses of dextromethorphan are expressed as the base.”
    The authors would like to apologize for any inconvenience caused.